000			01970 a2200541 4500
005			20250516200641.0
264		0	_c20140703
008			201407s 0 0 eng d
022			_a1532-6535
024	7		_a10.1038/clpt.2014.50 _2doi
040			_aNLM _beng _cNLM
100	1		_aSager, J E
245	0	0	_aFluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4. _h[electronic resource]
260			_bClinical pharmacology and therapeutics _cJun 2014
300			_a653-62 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdult
650	0	4	_aAntidepressive Agents, Second-Generation _xadministration & dosage
650	0	4	_aArea Under Curve
650	0	4	_aAryl Hydrocarbon Hydroxylases _xantagonists & inhibitors
650	0	4	_aBiotransformation
650	0	4	_aComputer Simulation
650	0	4	_aCytochrome P-450 CYP2C19
650	0	4	_aCytochrome P-450 CYP2D6 _xmetabolism
650	0	4	_aCytochrome P-450 CYP2D6 Inhibitors
650	0	4	_aCytochrome P-450 CYP3A _xmetabolism
650	0	4	_aCytochrome P-450 CYP3A Inhibitors
650	0	4	_aDextromethorphan _xpharmacokinetics
650	0	4	_aDrug Interactions
650	0	4	_aFemale
650	0	4	_aFluoxetine _xadministration & dosage
650	0	4	_aHalf-Life
650	0	4	_aHepatocytes _xdrug effects
650	0	4	_aHumans
650	0	4	_aLovastatin _xpharmacokinetics
650	0	4	_aMale
650	0	4	_aMidazolam _xpharmacokinetics
650	0	4	_aModels, Statistical
650	0	4	_aOmeprazole _xpharmacokinetics
650	0	4	_aStereoisomerism
700	1		_aLutz, J D
700	1		_aFoti, R S
700	1		_aDavis, C
700	1		_aKunze, K L
700	1		_aIsoherranen, N
773	0		_tClinical pharmacology and therapeutics _gvol. 95 _gno. 6 _gp. 653-62
856	4	0	_uhttps://doi.org/10.1038/clpt.2014.50 _zAvailable from publisher's website
999			_c23585789 _d23585789